Supplementary Tables S1 through S3 from The Intratumoral Balance between Metabolic and Immunologic Gene Expression Is Associated with Anti–PD-1 Response in Patients with Renal Cell Carcinoma

Authors:
  • MAMaria Libera Ascierto
    Maria Libera Ascierto
  • TMTracee L. McMiller
    Tracee L. McMiller
  • ABAlan E. Berger
    Alan E. Berger
  • LDLudmila Danilova
    Ludmila Danilova
  • RARobert A. Anders
    Robert A. Anders
  • GNGeorge J. Netto
    George J. Netto
  • HXHaiying Xu
    Haiying Xu
  • TPTheresa S. Pritchard
    Theresa S. Pritchard
  • JFJinshui Fan
    Jinshui Fan
  • CCChris Cheadle
    Chris Cheadle
  • LCLeslie Cope
    Leslie Cope
  • CDCharles G. Drake
    Charles G. Drake

Abstract
Supplementary Table S1: PD-L1+ RCC specimens used in this study. Supplementary Table S2: Genes differentially expressed in RCC based on whole genome microarray analysis, in patients responding or not to anti-PD-1 therapy (234 probe sets corresponding to 223 genes). Supplementary Table S3: Sixty genes included in custom multiplex qRT-PCR array to assess candidates from RCC whole genome microarray profiling.